TITLE

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder

AUTHOR(S)
George, J. N.
PUB. DATE
June 2008
SOURCE
Bone Marrow Transplantation;Jun2008, Vol. 41 Issue 11, p917
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the importance of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA). He remarks that TA-TMA's importance is documented not only by the experience of clinicians but also by extensive clinical investigation. He asserts that despite efforts to develop consensus diagnostic criteria, the syndrome of TA-TMA has resisted clear definition, accurate diagnosis and effective treatment.
ACCESSION #
32566155

 

Related Articles

  • Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Woywodt, A.; Haubitz, M.; Buchholz, S.; Hertenstein, B. // Bone Marrow Transplantation;Dec2004, Vol. 34 Issue 12, p1015 

    Summary:During hematopoietic stem cell transplantation (HSCT), endothelial damage is the pathological hallmark of veno-occlusive disease of the liver, thrombotic microangiopathy, capillary leak syndrome and graft-versus-host disease. Events prior to conditioning, the conditioning regimen itself...

  • Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Cho, B.-S.; Min, C.-K.; Eom, K.-S.; Kim, Y.-J.; Kim, H.-J.; Lee, S.; Cho, S.-G.; Kim, Y.; Kim, D.-W.; Lee, J.-W.; Min, W.-S.; Kim, C.-C. // Bone Marrow Transplantation;May2008, Vol. 41 Issue 9, p813 

    The impact of thrombotic microangiopathy (TMA) on outcome was studied in 148 patients with acute graft-versus-host disease (GVHD) (grade II). The Blood and Marrow Transplant Clinical Trials Network's definition for TMA was used to diagnose definite TMA. Probable TMA was diagnosed when...

  • Hematopoietic stem cell transplantation for autoimmune diseases in developing countries: current status and future prospectives. Voltarelli, J C; Ouyang, J // Bone Marrow Transplantation;Aug2003 Supplement 1, Vol. 32 Issue 1, pS69 

    Summary:In this paper we present preliminary results of hematopoietic stem cell transplantation for autoimmune diseases in Brazil and China. Chinese experience transplanting lupus is significant and the Brazilian experience with several autoimmune diseases is growing. We discuss peculiar...

  • Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Kovalszki, A.; Schumaker, G. L.; Klein, A.; Terrin, N.; White, A. C. // Bone Marrow Transplantation;Jun2008, Vol. 41 Issue 11, p965 

    We performed a retrospective analysis of muscle strength testing obtained following sibling or unrelated donor hematopoietic stem cell transplant (HSCT) between 1 January 1999 and 31 December 2003 in a cohort of 44 subjects at Tufts-New England Medical Center. Maximal inspiratory pressure...

  • Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Lerner, D; Dandoy, C; Hirsch, R; Laskin, B; Davies, S M; Jodele, S // Bone Marrow Transplantation;Jun2014, Vol. 49 Issue 6, p862 

    A letter to the editor is presented regarding pericardial effusion (PEF), which is a complication of hematopoietic stem cells transplantation (HSCT) in pediatric recipients with thrombotic microangiopathy.

  • Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Willems, E.; Baron, F.; Seidel, L.; Frère, P.; Fillet, G.; Beguin, Y. // Bone Marrow Transplantation;Apr2010, Vol. 45 Issue 4, p689 

    The role of conditioning intensity on occurrence of thrombotic microangiopathy (TMA) after allogeneic hematopoietic cell transplantation (HCT) has remained unclear thus far. Here, we retrospectively compared the incidence of TMA in patients given allogeneic hematopoietic stem cells after either...

  • Update in Haematopoietic Stem Cell Transplantation. Cristina, Berteanu; Maria, Stoica; G. A., Stoica; Daniela, Cernea; Alina, Tănase; Sanda-Maria, Copotoiu; Klara, Brânzaniuc; L., Azamfirei; C., Cirstoiu; A., Rosin // Acta Medica Marisiensis;Aug2011, Vol. 57 Issue 4, p384 

    The authors review the most important aspects of stem cell transplantation, starting with its objectives, general guidelines and specific issues in rare diseases, and series of complications arising from this complicated therapeutic procedure.

  • Hematopoietic stem cell transplantation activity in Europe 1999. Gratwohl, A; Passweg, J; Baldomero, H; Urbano-Ispizua, A // Bone Marrow Transplantation;5/1/2001, Vol. 27 Issue 9, p899 

    This survey on transplantation of hematopoietic stem cells from blood or bone marrow in Europe, the 10th in a series, reports the numbers of transplants performed in 1999 and concentrates on changes in indications and donor types. Members of the European Group for Blood and Marrow...

  • Plasmapheresis for Thrombotic Thrombocytopenic Purpura following Bone Marrow Transplantation. Kolker; Sviri; Linton; Or; Nagler; Shapira // Acta Haematologica;2001, Vol. 105 Issue 3, p156 

    Recognition of thrombotic thrombocytopenic purpura (TTP)/hemolytic uremic syndrome (HUS) following bone marrow transplantation (BMT) has increased in recent years. The use of plasma exchange has greatly improved the outlook of de novo TTP. Fewer data are available on its use in post-BMT TTP but...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics